X
    X
    X
    X
     

    Overview

    Printer Friendly Version

    Jim Peterka is a member of Locke Lord's IP Pharmaceutical and Biotechnology and IP Litigation groups, and focuses his practice primarily on Hatch-Waxman pharmaceutical patent litigation. Jim regularly counsels generic pharmaceutical and biotechnology companies in connection with patent issues and in all aspects of patent litigation. His Hatch-Waxman experience ranges from pre-litigation activities, including patent design-around and invalidity counseling and preparation of Paragraph IV notice letters, through discovery, claim construction proceedings, trial, and appeal. He also represents clients in connection with a variety of FDA regulatory issues.

    Read More
    10
    2

    Find News, Events, Notable Matters, and More
    SEARCH

    Showing Results for

    57b896a7-fddc-4925-828b-083ab4b16ea4

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.